Wednesday, April 3, 2013. 1:00 - 5:00pm
San Diego Convention Center, Room 6F
San Diego, CA
Hemophilia Management: Collaborating in a New Era to Optimize Cost and Clinical Outcomes in Managed Care
Hot Topics Include:
- Clinical overview of general hemophilia and hemophilia with inhibitors, including emerging treatment options, and key implications for managed care
- Implementation of guidelines and standards of care to cost effectively manage hemophilia
- Strategies and practical resources to improve collaboration across the comprehensive care team including 340B pharmacy providers
- Multidisciplinary perspectives, including Hemophilia Treatment Centers and Specialty Pharmacy, to showcase best practices in care coordination
- Critical evaluation of hemophilia specialty pharmacy management services
|
Jeffrey D. Dunn, PharmD, MBA
Formulary and Contract Manager SelectHealth, Inc. Salt Lake City, UT |
|
Marion Koerper, MD
Medical Advisor, National Hemophilia Foundation University of California, San Francisco (UCSF) School of Medicine San Francisco, CA |
|
Raulo Frear, PharmD
General Manager Regence Rx Boise, ID |
|
William D. LaPiana, M.T. (A.S.C.P.)
Regional Director / Advanced Therapies Accredo, An Express Scripts Co. Raleigh-Durham, NC |
|
Sue Geraghty, RN, MBA
Nurse Coordinator University of Colorado Denver Hemophilia and Thrombosis Center Denver, CO |
Who Should Attend?
This activity is designed to meet the educational needs of pharmacists, physicians and other healthcare professionals attending the AMCP 25th Annual Meeting & Expo.
Statement of Need/Program Overview
Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans and employers in meeting clinical and/or financial goals. This symposium, joint sponsored by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders.
Educational Objectives
After completing this activity, the participant should be better able to:
- Review the pathophysiology of general hemophilia and hemophilia with inhibitors, including the impact on clinical and economic outcomes, and patients' quality of life
- Assess the available hemophilia therapies for both children and adults, with and without inhibitors
- Implement the Medical and Scientific Advisory Council (MASAC) Quality of Care Guidelines for the treatment of hemophilia
- Evaluate current and emerging hemophilia medical and pharmacy benefit models, including specialty pharmacy management services
- Employ collaborative care strategies and resources for the comprehensive care team, including Hemophilia Treatment Centers (HTCs), to improve care coordination for patients with hemophilia
Agenda
Wednesday, April 3, 2013
San Diego Convention Center
Room 6F
| 1:00 pm | Registration and Lunch |
| 1:30 pm |
Introduction and Objectives/Opening Comments
Jeffrey D. Dunn, PharmD, MBA, Moderator |
| 1:45 pm |
Current Practices and Trends in the Treatment of Hemophilia: A Primer for Managed Care Professionals Marion Koerper, MD |
| 2:30 pm |
Managed Care Strategies for General Hemophilia and Hemophilia with Inhibitors
Raulo Frear, PharmD |
| 3:10 pm |
Applying a Collaborative Approach to Hemophilia Management Among Members of the Comprehensive Care Team
Sue Geraghty, RN, MBA |
3:45 pm |
Hemophilia Specialty Pharmacy Management Services: Steps for Success
William D. LaPiana, M.T. (A.S.C.P.) |
4:20 pm | Audience Question and Answer Session | 4:50 pm |
Key Takeaways and Closing Remarks
Post-Activity Assessment and Evaluation Jeffrey D. Dunn, PharmD, MBA, Moderator |
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine, National Hemophilia Foundation, and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
|
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 3.5 contact hours (0.35 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0809-9999-13-268-L01-P)
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Type of Activity: Application
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Pre-registration will close at 12:00 pm on April 1. Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
Click here to register.